Dainippon Sumitomo Pharma Co., Ltd. - Strategy and SWOT Report

Date: February 25, 2014
Pages: 40
Price:
US$ 175.00
License [?]:
Publisher: MarketLine
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: D56E9FA5C84EN
Leaflet:

Download PDF Leaflet

Dainippon Sumitomo Pharma Co., Ltd. - Strategy and SWOT Report
Dainippon Sumitomo Pharma Co., Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:
  • Detailed information on Dainippon Sumitomo Pharma Co., Ltd. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Dainippon Sumitomo Pharma Co., Ltd. in the form of a SWOT analysis
  • An in-depth view of the business model of Dainippon Sumitomo Pharma Co., Ltd. including a breakdown and examination of key business segments
  • Intelligence on Dainippon Sumitomo Pharma Co., Ltd.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Dainippon Sumitomo Pharma Co., Ltd., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Dainippon Sumitomo Pharma (DSP or 'the group') is a Japan-based global provider of pharmaceutical products. It is a subsidiary of Sumitomo Chemical. The group primarily operates in Asia and North America. It is headquartered in Osaka, Japan, and employed 7,129 people as of March 31, 2013. The group recorded revenues of JPY347,724 million (approximately $4,207.5 million) during the financial year ended March 2013 (FY2013), a decrease of 0.8% over FY2012. The operating profit of the group was JPY25,044 million (approximately $303 million) in FY2013, an increase of 22.8% over FY2012. The net profit was JPY10,044 million (approximately $121.5 million) in FY2013, an increase of 16.4% over FY2012.

Reasons to Purchase:
  • Gain understanding of Dainippon Sumitomo Pharma Co., Ltd. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Dainippon Sumitomo Pharma Co., Ltd. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Dainippon Sumitomo Pharma Co., Ltd.’s business structure, strategy and prospects
COMPANY SNAPSHOT

  Dainippon Sumitomo Pharma Co., Ltd.: Company Overview
  Dainippon Sumitomo Pharma Co., Ltd.: Overview and Key Facts
    Dainippon Sumitomo Pharma Co., Ltd.: Overview
    Dainippon Sumitomo Pharma Co., Ltd.: Key Facts
  Dainippon Sumitomo Pharma Co., Ltd.: Key Employees
  Dainippon Sumitomo Pharma Co., Ltd.: Major Products and Services
  Dainippon Sumitomo Pharma Co., Ltd.: Company History
  Dainippon Sumitomo Pharma Co., Ltd.: Management Statement
  Dainippon Sumitomo Pharma Co., Ltd.: Locations and Subsidiaries
  Dainippon Sumitomo Pharma Co., Ltd.: Key Competitors
Dainippon Sumitomo Pharma Co., Ltd.: Company Analysis
  Dainippon Sumitomo Pharma Co., Ltd.: Business Description
  Dainippon Sumitomo Pharma Co., Ltd.: SWOT Analysis
    Dainippon Sumitomo Pharma Co., Ltd.: SWOT Overview
    Dainippon Sumitomo Pharma Co., Ltd.: Strengths
    Dainippon Sumitomo Pharma Co., Ltd.: Weaknesses
    Dainippon Sumitomo Pharma Co., Ltd.: Opportunities
    Dainippon Sumitomo Pharma Co., Ltd.: Threats
  Dainippon Sumitomo Pharma Co., Ltd.: Corporate Financial Deals Activity
  Dainippon Sumitomo Pharma Co., Ltd.: Financial Deals Overview
  Dainippon Sumitomo Pharma Co., Ltd.: Targets and Partners
  Dainippon Sumitomo Pharma Co., Ltd.: Top Deals 2010 - 2014YTD
  Dainippon Sumitomo Pharma Co., Ltd.: Advisors
    Dainippon Sumitomo Pharma Co., Ltd.: Top Legal Advisors
    Dainippon Sumitomo Pharma Co., Ltd.: Top Financial Advisors
  Dainippon Sumitomo Pharma Co., Ltd.: Mergers and Acquisitions
  Dainippon Sumitomo Pharma Co., Ltd.: Partnership
  Dainippon Sumitomo Pharma Co., Ltd.: Divestments
Dainippon Sumitomo Pharma Co., Ltd.: Recent Developments
  Dainippon Sumitomo Pharma Co., Ltd.: News and Events Summary
  Dainippon Sumitomo Pharma Co., Ltd.: Business Expansion
  Dainippon Sumitomo Pharma Co., Ltd.: Financial Deals
  Dainippon Sumitomo Pharma Co., Ltd.: Financial Performance
  Dainippon Sumitomo Pharma Co., Ltd.: Regulatory and Legal Events
  Dainippon Sumitomo Pharma Co., Ltd.: Research & Development
  Dainippon Sumitomo Pharma Co., Ltd.: Strategy and Operations

APPENDIX

  Contact Us
  Methodology
  Definitions
  About MarketLine

LIST OF TABLES

Table 1: Dainippon Sumitomo Pharma Co., Ltd.: Key Facts
Table 2: Dainippon Sumitomo Pharma Co., Ltd.: Key Employees
Table 4: Dainippon Sumitomo Pharma Co., Ltd.: Key Competitors
Table 5: Dainippon Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2010 - YTD 2014)
Table 6: Dainippon Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Table 7: Dainippon Sumitomo Pharma Co., Ltd.: Targets and Partners
Table 8: Dainippon Sumitomo Pharma Co., Ltd.: Top Deals 2010 - 2014YTD
Table 9: Dainippon Sumitomo Pharma Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 10: Dainippon Sumitomo Pharma Co., Ltd.: Financial Advisor Ranking by Value (US$m)
Table 11: Dainippon Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2010 - YTD 2014)
Table 12: Dainippon Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2010 - YTD 2014)
Table 13: Dainippon Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2010 - YTD 2014)
Table 14: Dainippon Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2010 - YTD 2014)
Table 15: Dainippon Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2010 - YTD 2014)
Table 16: Dainippon Sumitomo Pharma Co., Ltd.: Divestments by Geography (2010 - YTD 2014)
Table 17: Dainippon Sumitomo Pharma Co., Ltd.: News and Events Summary
Table 18: Dainippon Sumitomo Pharma Co., Ltd.: Business Expansion
Table 19: Dainippon Sumitomo Pharma Co., Ltd.: Financial Deals
Table 20: Dainippon Sumitomo Pharma Co., Ltd.: Financial Performance
Table 21: Dainippon Sumitomo Pharma Co., Ltd.: Regulatory and Legal Events
Table 22: Dainippon Sumitomo Pharma Co., Ltd.: Research & Development
Table 23: Dainippon Sumitomo Pharma Co., Ltd.: Strategy and Operations

LIST OF FIGURES

Figure 1: Dainippon Sumitomo Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2010 - YTD 2014)
Figure 2: Dainippon Sumitomo Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Figure 3: Dainippon Sumitomo Pharma Co., Ltd.: M&A Volume and Value Trend (2010 - YTD 2014)
Figure 4: Dainippon Sumitomo Pharma Co., Ltd.: M&A Activity by Geography (2010 - YTD 2014)
Figure 5: Dainippon Sumitomo Pharma Co., Ltd.: Partnership Volume and Value Trend (2010 - YTD 2014)
Figure 6: Dainippon Sumitomo Pharma Co., Ltd.: Partnership Trend by Deal Type (2010 - YTD 2014)
Figure 7: Dainippon Sumitomo Pharma Co., Ltd.: Divestments Volume and Value Trend (2010 - YTD 2014)
Figure 8: Dainippon Sumitomo Pharma Co., Ltd.: Divestments by Geography (2010 - YTD 2014)
Skip to top


Ask Your Question

Dainippon Sumitomo Pharma Co., Ltd. - Strategy and SWOT Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: